# Investigating the Clinical Utility of the MDS

> **NCT03109327** · — · COMPLETED · sponsor: **Orlucent, Inc** · enrollment: 250 (actual)

## Conditions studied

- Skin Lesion
- Melanoma
- Moles

## Interventions

- **DIAGNOSTIC_TEST:** Melanoma Detection System -MDS

## Key facts

- **NCT ID:** NCT03109327
- **Lead sponsor:** Orlucent, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2020-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03109327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03109327, "Investigating the Clinical Utility of the MDS". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03109327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*